Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) (347659)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Next deadline: Aug 2, 2024

Later deadlines: Aug 1, 2025

Grant amount: Up to US $500,000

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

The purpose of this reissued Funding Opportunity Announcement (FOA) is to support high-risk, high-impact, early discovery research on vaccine approaches to prevent acquisition of or ongoing infection by HIV. In keeping with the high-risk, high-impact nature of this research, this FOA supports a Go/No-Go approach to funding high risk research, which is significantly different from most R01 projects. Continued funding for the full award duration is dependent upon achieving negotiated Go/No-Go criteria by the end of Year 2.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.